| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Ulipristal acetate |
| Brand | Esmya® |
| Indication | For the intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. |
| Assessment Process | |
| Rapid review commissioned | 17/05/2016 |
| Rapid review completed | 31/05/2016 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |